BioNTech SE (ETR:22UA)
89.05
+1.20 (1.37%)
At close: Nov 28, 2025
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€465,520
Profits / Employee
€84,406
Market Cap
21.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
BioNTech SE News
- 4 days ago - BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration - GlobeNewsWire
- 6 days ago - CureVac (CVAC) Moves Closer to BioNTech Deal for mRNA Innovations - GuruFocus
- 13 days ago - BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript - Seeking Alpha
- 17 days ago - Pfizer Cuts BioNTech Stake by More Than Half - GuruFocus
- 17 days ago - Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up - Reuters
- 17 days ago - Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run - Benzinga
- 17 days ago - Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run - Benzinga
- 17 days ago - 4 stocks to watch on Thursday: DIS, RIO, JD, BNTX - Seeking Alpha